Description

• Reduction of excess abdominal fat: Tesamorelin is specifically approved to reduce excess abdominal fat (visceral fat) in HIV-infected patients with lipodystrophy, a condition characterized by abnormal body fat distribution. Studies show significant reductions in visceral adipose tissue (VAT) with Tesamorelin compared to placebo.

• Increased muscle mass: Tesamorelin can help preserve and increase lean muscle mass, which is important for individuals who want to lose fat without losing muscle. It promotes lean muscle growth and improves recovery.
• Improved body composition: By reducing visceral fat and increasing lean muscle mass, Tesamorelin can contribute to overall improved body composition.
• Enhanced metabolic health: Tesamorelin may help improve metabolic health by reducing insulin resistance and supporting cardiovascular health. It has also been shown to improve lipid profiles and insulin sensitivity.
• Potential improvements in cognitive function: Some studies suggest that Tesamorelin may support brain health and neurocognitive function.
• Improved sleep quality: Tesamorelin may contribute to improved sleep quality.
• Enhanced energy and vitality: Patients may experience increased energy and vitality with Tesamorelin therapy.
• Increased strength and stamina: Tesamorelin may lead to increased strength and stamina.
• Accelerated workout recovery: Tesamorelin can enhance recovery after workouts.
• Other potential benefits: Some sources list other potential benefits, including increased bone density, decreased joint and muscle pain, lower cholesterol, improved skin elasticity, and healthier hair and nails.